DAMPs, PAMPs, and the origins of SIRS in bacterial sepsis

Shock

Volumn 39, Issue 1, 2013, Pages 113-114

  Gentile, Lori F ^a   Moldawer, Lyle L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; DROTRECOGIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; MITOCHONDRIAL DNA; PROCALCITONIN;

ANTHRAX; BACILLUS ANTHRACIS; DAMAGE ASSOCIATED MOLECULAR PATTERN; DISEASE MARKER; EDITORIAL; ESCHERICHIA COLI; MOLECULAR DYNAMICS; PATHOGEN ASSOCIATED MOLECULAR PATTERN; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; ANTHRAX; BACTEREMIA; DNA, BACTERIAL; DNA, MITOCHONDRIAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84871963430     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318277109c     Document Type: Editorial

References (13)

1. Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, Moldawer LL, Moore FA: Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 72(6):1491-1501, 2012.
2. Moore FA, Moore EE: Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 75(2):257-277, 1995.
3. Fukushima R, Alexander JW, Gianotti L, Pyles T, Ogle CK: Bacterial translocationrelated mortality may be associated with neutrophil-mediated organ damage. Shock 3(5):323-328, 1995.
4. Matzinger P: The danger model: A renewed sense of self. Science 296(5566): 301-305, 2002.
5. Sansonetti PJ: The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 7(12):1237-1242, 2006.
6. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464(7285):104-107, 2010.
7. Sursal T, Stearns-Kurosawa D, Itagak K, Oh S, Kurosawa S, Hauser C: Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile SIRS and quantify inflammatory tissue injury in nonhuman primates. Shock 39:55-62, 2012.
8. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, et al.: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306(23): 2594-2605, 2011.
9. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 9(5):517-524, 2003.
10. Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL: Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23(6):488-493, 2005.
11. Ventetuolo CE, Levy MM: Biomarkers: Diagnosis and risk assessment in sepsis. Clin Chest Med 29(4):591-603, 2008.
12. Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE: High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 33(8):1347-1353, 2007.
13. Cohen MJ, Brohi K, Calfee CS, Rahn P, Chesebro BB, Christiaans SC, Carles M, Howard M, Pittet JF: Early release of high mobility group box nuclear protein 1 after severe trauma in humans: Role of injury severity and tissue hypoperfusion. Crit Care 13(6):R174, 2009.